North America Benign Prostatic Hyperplasia Devices Market, By Procedure Type (Transurethral Resection of the Prostate (TURP), Prostatic Urethral Lift (PUL), Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Stenting/Implants, Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), Country (U.S., Mexico, Canada) Industry Trends and Forecast to 2028.
Data Bridge Market Research analyses that the North America benign prostatic hyperplasia devices market to be growing at CAGR of 12.4% in the forecast period of 2021-2028.
Benign prostatic hyperplasia (BPH) is defined as a non-cancerous enlargement of prostate gland. Benign prostatic hypertrophy is also called benign prostatic obstruction or benign prostatic hypertrophy. It is a condition that mostly occurs in men. The prostate gland typically goes through two major growth stages as man ages. The first phase occurs at the onset of puberty, when the prostate gland doubles in size, while the second phase of growth occurs around age 25 and continues for most of a man's life. BPH usually develop with the second stage of growth.
The rise in the prevalence of benign prostatic hyperplasia amongst men and increasing risk factors will cushion the demand for advanced medical devices and act as major drivers influencing the growth of the market of benign prostatic hyperplasia. Furthermore, surge in the demand for minimally invasive treatment, rise in the number geriatric population and developments associated with innovate and advanced BPH treatment devices are the factors that will enhance the growth of benign prostatic hyperplasia devices market. Also, the growing popularity of robotic assistance surgical techniques and favourable reimbursement facilities will accelerate the market growth rate.
Moreover, rising healthcare sector in emerging economies and technological advancement related with benign prostatic hyperplasia devices will create beneficial opportunities for the market growth.
However, the high cost associated with benign prostatic hyperplasia devices and side effects of the BPH medications act as market restraints that will obstruct market growth. Less awareness about prostate health among men and product recalls will further challenge the benign prostatic hyperplasia devices market.
This North America benign prostatic hyperplasia devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America benign prostatic hyperplasia devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Benign Prostatic Hyperplasia Devices Market Scope and Market Size
North America benign prostatic hyperplasia devices market is segmented on the basis of procedure type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of procedure type, the benign prostatic hyperplasia devices market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift (PUL), prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others. The others have been further sub-segmented into high-intensity frequency ultrasound (HIFU), water-induced thermotherapy, prostatic artery embolization (PAE) and others.
- On the basis of end user, the benign prostatic hyperplasia devices market is bifurcated into hospitals and clinics, ambulatory surgical centers and others.
North America Benign Prostatic Hyperplasia Devices Market Country Level Analysis
North America benign prostatic hyperplasia devices market is analysed and market size insights and trends are provided by country, procedure type and end user as referenced above.
The countries covered in North America benign prostatic hyperplasia devices market report are U.S., Canada and Mexico.
The country section of the North America benign prostatic hyperplasia devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
North America benign prostatic hyperplasia devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America benign prostatic hyperplasia devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America benign prostatic hyperplasia devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and North America Benign Prostatic Hyperplasia Devices Market Share Analysis
North America benign prostatic hyperplasia devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America benign prostatic hyperplasia devices market.
The major players covered in the North America benign prostatic hyperplasia devices market report are KARL STORZ, OmniGuide Holdings, Inc., Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, Medifocus Inc., biolitec AG, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : North America Benign Prostatic Hyperplasia Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.